YIH
HOWL icon

Y-Intercept (HK)’s Werewolf Therapeutics HOWL Stock Holding History

Y-Intercept (HK)’s Portfolio HOWL Stock Details HOWL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-84,421
Closed -$92K – 1766
2025
Q2 		$92K Buy
+84,421
New +$86.9K ﹤0.01% 1539
2024
Q2 		– Sell
-14,154
Closed -$91.7K – 1603
2024
Q1 		$91.7K Buy
+14,154
New +$82.5K 0.01% 1289
2022
Q3 		– Sell
-11,124
Closed -$45K – 1100
2022
Q2 		$45K Buy
+11,124
New +$50.8K 0.01% 759

Other funds holding HOWL

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
DF
DC Funds Mclean, Virginia $1.49M AUM 18.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Y-Intercept (HK)'s HOWL Position: Q3 2025 in Review

Y-Intercept (HK) sold out of Werewolf Therapeutics (HOWL) in Q3 2025, closing a stake of 84,421 shares — an estimated $92K sold.

Y-Intercept (HK) first reported a position in HOWL in Q2 2022 and held it in 3 quarters. The position peaked at $92K in Q2 2025. 62 funds tracked by Wall St. Rank hold HOWL as of Q3 2025.

  • Y-Intercept (HK) reported no remaining Werewolf Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Y-Intercept (HK) sold 84,421 Werewolf Therapeutics shares in Q3 2025, an estimated $92K.
  • Y-Intercept (HK) first reported a position in Werewolf Therapeutics in Q2 2022 and held it in 3 quarters.
  • Y-Intercept (HK)'s Werewolf Therapeutics position peaked at $92K in Q2 2025.
  • 62 funds tracked by Wall St. Rank held Werewolf Therapeutics as of Q3 2025.

Based on Y-Intercept (HK)'s 13F filing for Q3 2025, filed 31 Oct 2025.